Barry Kobrin
Impact in
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- CAR-T cell therapy research
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 12
- Immunology 10
- Immunotherapy and Immune Responses 7
- Immune Cell Function and Interaction 2
- Co-authors
- Christine Milcarek (4 shared papers)Sherie L. Morrison (4 shared papers)Elizabeth M. Jaffee (4 shared papers)Steven Piantadosi (2 shared papers)Barbara Biedrzycki (2 shared papers)John L. Cameron (1 shared paper)Sara Solt (1 shared paper)Beth Onners (1 shared paper)
- Journals
- The Journal of Immunology (3 papers)Proceedings of the National Academy of Sciences (2 papers)Journal of Clinical Oncology (2 papers)Cytotherapy (1 paper)Immunotechnology (1 paper)
- Partner nations
- United StatesIsrael
In The Last Decade
Barry Kobrin
18 papers receiving 797 citations
Peers
Comparison fields: 5 of 71
- Immunology 441
- Oncology 442
- Biotechnology 104
- Radiology, Nuclear Medicine and Imaging 139
- Molecular Biology 278
Countries citing papers authored by Barry Kobrin
This map shows the geographic impact of Barry Kobrin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry Kobrin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry Kobrin more than expected).
Fields of papers citing papers by Barry Kobrin
This network shows the impact of papers produced by Barry Kobrin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry Kobrin. The network helps show where Barry Kobrin may publish in the future.
Co-authors
The 25 scholars most cited alongside Barry Kobrin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 295 | |
| 2 | 2009 | 178 | |
| 3 | 1991 | 105 | |
| 4 | 2011 | 54 | |
| 5 | 1986 | 35 | |
| 6 | 1995 | 33 | |
| 7 | 1995 | 27 | |
| 8 | 1990 | 15 | |
| 9 | 2005 | 12 | |
| 10 | 2014 | 11 | |
| 11 | 1986 | 9 | |
| 12 | 1998 | 8 | |
| 13 | 2011 | 8 | |
| 14 | 1991 | 8 | |
| 15 | 1981 | 7 | |
| 16 | 1988 | 5 | |
| 17 | Establishment, molecular rescue, and expression of 123AV16-1, a tumor-reactive human monoclonal antibody. | 1994 | 4 |
| 18 | Production of novel immunoglobulin molecules by gene transfection. | 1986 | 2 |
About Barry Kobrin
Barry Kobrin is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology, Molecular Biology, Oncology and Genetics, having authored 18 papers that have together received 816 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (12 papers), Immunotherapy and Immune Responses (7 papers), RNA and protein synthesis mechanisms (4 papers), Glycosylation and Glycoproteins Research (3 papers), Lymphoma Diagnosis and Treatment (2 papers), CAR-T cell therapy research (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Immunology (441 citations), Oncology (442 citations), Biotechnology (104 citations), Radiology, Nuclear Medicine and Imaging (139 citations) and Molecular Biology (278 citations). Barry Kobrin has collaborated with scholars based in United States and Israel. Frequent co-authors include Christine Milcarek, Sherie L. Morrison, Elizabeth M. Jaffee, Steven Piantadosi, Barbara Biedrzycki, John L. Cameron, Sara Solt, Beth Onners, Rajni Sharma and Dan Laheru. Their work appears in journals such as The Journal of Immunology, Proceedings of the National Academy of Sciences, Journal of Clinical Oncology, Cytotherapy and Immunotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.